Wu, Wesley

The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies

Swanson, K., Wu, W., Bulaong, N. L., Pak, J. E., & Zou, J. (2025) · Nature

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 169

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

Peluso, M. J., Takahashi, S., Hakim, J., Kelly, J. D., Torres, L., Iyer, N. S., Turcios, K., Janson, O., Munter, S. E., Thanh, C., et al. (2021) · Science Advances

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing

Cited by 130

The Virtual Lab: AI Agents Design New SARS-CoV-2 Nanobodies with Experimental Validation

Swanson, K., Wu, W., Bulaong, N. L., Pak, J. E., & Zou, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory)

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 56

Genomic and serologic characterization of enterovirus A71 brainstem encephalitis

Leon, K. E., Schubert, R. D., Casas-Alba, D., Hawes, I. A., Ramachandran, P. S., Ramesh, A., Pak, J. E., Wu, W., Cheung, C. K., Crawford, E. D., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation

Infectious Encephalopathies and EncephalitisViral Infections and Immunology Research

Cited by 32

High-yield production of recombinant human myelin oligodendrocyte glycoprotein in SHuffle bacteria without a refolding step

Wu, W., Gupta, S., Sagan, S. A., Moseley, C. E., Zamvil, S. S., & Pak, J. E. (2024) · Journal of Immunological Methods

Protein purification and stabilityMultiple Sclerosis Research Studies

Cited by 3